About the Cardiovascular Institute

New insights into heart and cardiovascular disease have dramatically changed our thinking about the fundamental nature of cardiovascular disease and our approach to its prevention, diagnosis, and treatment. By integrating three corresponding disciplines — molecular cardiology, regenerative cardiology, and cardiac imaging — Icahn School of Medicine’s Cardiovascular Institute in New York City has made great headway in developing new approaches to enhance patient care.

As cardiovascular disease gains a foothold across the planet, Mount Sinai has been at the forefront of cardiovascular translational research. Mount Sinai leveraged its already well-established translational research program to create the Cardiovascular Research Institute. The Institute traces its roots back to the Zena and Michael A. Wiener Cardiovascular Institute, which was created to more closely connect Mount Sinai’s research advances with the clinical practice of medicine.

In 2006, the Zena and Michael A. Wiener Cardiovascular Institute joined forces with the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, forming Mount Sinai Heart. Today, the Cardiovascular Research Institute is the translational research hub of Mount Sinai Heart.

The rapid translation of innovative research concepts into prevention, diagnosis, and therapy means that patients receive multidisciplinary treatment of unprecedented quality. Our programs span patient care from the earliest stages of life — our pediatric cardiologists can detect cardiac disease in the unborn fetus — well into advanced age through specialized geriatric cardiology.